ask our doctors

Amyloidosis Immunoglobulin

Get the facts on Amyloidosis Immunoglobulin treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Amyloidosis Immunoglobulin prevention, screening, research, statistics and other Amyloidosis Immunoglobulin related topics. We answer all your qestions about Amyloidosis Immunoglobulin.

Question: I need to verify what is primary amyloidosis. http://www.iupui.edu/~amyloid/primary.htm?... is this true: Primary amyloidosis is a disease caused by the abnormal accumulation of protein molecules in body tissues. These proteins are fragments of immunoglobulin (antibody) molecules which are normally present in the blood to give protection against bacteria and other infectious agents. Normally, antibody molecules are constantly being synthesized by cells of the immune system and then, after a finite life span, degraded so that there is a balance between production and degradation In this way our active immune system protects our bodies from a constantly changing array of infectious bacteria and viruses. In primary amyloidosis a defect occurs in the immune system. Excessive amounts of certain antibody molecules are produced and fragments of these molecules get deposited in tissues. These tissue deposits, as they enlarge, damage normal tissues and cause the disease that we know as primary amyloidosis. The information is from Indiana University School of Medicine Can this medical school be trusted with providing correct information? Hey Anj, can wekipedia even be trusted, becuase it can be written by any one and its always changing.

Answer: That's more or less correct. In short primary amylodosis is a metabolic defect which results in abnormal proteins depositing in the various tissues of the body, ie heart, kidneys, brain etc etc. There are several kinds of amyloidosis, nearly all of them with similar outcome. Wikipedia have a more lucid explanation. Wish you the very best


Amyloidosis Immunoglobulin News

Cell Therapy - Technologies, Markets and Companies

MarketWatch (press release)
... treatment of anemia 202Stem cell therapy of hemoglobinopathies 203Stem cells for treatment of immunoglobulin-light chain amyloidosis 203Future prospects of cell therapy of hematological disorders 203Cell therapy for immunological disorders 204Role ...
 

Protein Folding and Disease: The Path from Bench to Bedside

Genetic Engineering News
The latter strategy has led to the discovery of a first-in-class small molecule drug to treat gain-of-toxic-function transthyretin amyloid diseases associated with neuro- and cardio-degeneration. Specifically, Dr. Kelly described the development of the ...
 

U.S. Patents Awarded to Inventors in Tennessee (Feb. 7)

Targeted News Service (subscription)
The abstract of the patent published by the US Patent and Trademark Office states: "Methods and related immunoglobulin peptides and fragments thereof are disclosed that enhance the cell-mediated immune response of a patient to deposits of amyloid ...